The objects of the study were to determine: (1) whether United Kingdom ophthalmologists who used argon lasers had the elevation of colour-contrast thresholds previously discovered and (2) whether other users of argon lasers showed any unusual loss of colour vision. A total of 1072 UK ophthalmologists filled in a questionnaire about their professional use of lasers, the length of time spent operating, and their out-of-doors activities. Their colour vision was then tested by a new sensitive system, and if any abnormality was detected, a clinical eye examination was performed. The results were as follows: (1) Colour vision testing was shown to be reliable. Any self-selection bias was excluded. Test–retest variability was small. Normal results did not change during the survey. (2) A number of men with high red–green thresholds were discovered. Some were aware of their congenital insensitivity. The frequency of all such defects was less than the known incidence of congenital colour deficiency in the male population. (3) Additionally a number of high tritan (blue–yellow) thresholds were encountered, some associated with reported diabetes and hypertension. In other cases of this type, undetected or unacknowledged systemic disease may be present. (4) After making allowance for all these incidental causes of loss of colour vision, and for the effect of age on colour vision (which is very small) only four of the sample were >2 SD above normal. (5) However, the average blue–yellow thresholds of ophthalmologists were slightly and highly significantly raised compared with normal, in the first year of the survey. During the second and third years, the mean thresholds declined to normal. Similar but less significant findings were found for protan thresholds. It is concluded that the enhanced safety precautions recently introduced are associated with a recovery of colour vision in this population, demonstrating that any changes to individuals were reversible. Colour vision screening has proved able to detect mild ocular abnormalities due to systemic and congenital disease.
[1]
M. Mainster,et al.
Potential laser hazards to the clinician during photocoagulation.
,
1987,
American journal of ophthalmology.
[2]
Duncan Cramer,et al.
Quantitative data analysis for social scientists
,
1990
.
[3]
G B Arden,et al.
Changes in colour contrast sensitivity associated with operating argon lasers.
,
1989,
The British journal of ophthalmology.
[4]
B. Friström.
Peripheral colour contrast thresholds in ocular hypertension and glaucoma.
,
2009,
Acta ophthalmologica Scandinavica.
[5]
D. Foster,et al.
Abnormalities in hue discrimination revealed with very brief stimuli in diabetes mellitus and in optic neuritis
,
1990
.
[6]
G B Arden,et al.
Using argon laser blue light reduces ophthalmologists' color contrast sensitivity. Argon blue and surgeons' vision.
,
1989,
A M A Archives of Ophthalmology.
[7]
A. J. Allnutt.
Safety with Lasers and other Optical Sources
,
1981
.
[8]
Curtis L. Meinert,et al.
Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.
,
1978,
Ophthalmology.
[9]
W. Hart.
Acquired dyschromatopsias.
,
1987,
Survey of ophthalmology.
[10]
K. Ruddock.
The effect of age upon colour vision. I. Response in the receptoral system of the human eye.
,
1965,
Vision research.
[11]
W. Spileers,et al.
Peripheral color contrast. A new screening test for preglaucomatous visual loss.
,
1991,
Investigative ophthalmology & visual science.
[12]
G. Arden,et al.
A survey of color discrimination in German ophthalmologists. Changes associated with the use of lasers and operating microscopes.
,
1991,
Ophthalmology.